156 related articles for article (PubMed ID: 22639171)
1. Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients.
Lowenstein PR; Castro MG
Clin Immunol; 2018 Apr; 189():43-51. PubMed ID: 28720549
[TBL] [Abstract][Full Text] [Related]
2. Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model.
Maes W; Van Gool SW
Cancer Immunol Immunother; 2011 Feb; 60(2):153-60. PubMed ID: 21120655
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapies for malignant glioma.
Boussiotis VA; Charest A
Oncogene; 2018 Mar; 37(9):1121-1141. PubMed ID: 29242608
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of immunotherapy in high-grade glioma: learning from the past to shape future perspectives.
Sferruzza G; Consoli S; Dono F; Evangelista G; Giugno A; Pronello E; Rollo E; Romozzi M; Rossi L; Pensato U
Neurol Sci; 2024 Jun; 45(6):2561-2578. PubMed ID: 38308708
[TBL] [Abstract][Full Text] [Related]
5. Exosomes as drug delivery systems in glioma immunotherapy.
Hao X; Wang S; Wang L; Li J; Li Y; Liu J
J Nanobiotechnology; 2024 Jun; 22(1):340. PubMed ID: 38890722
[TBL] [Abstract][Full Text] [Related]
6. Glioma Stem Cells-Features for New Therapy Design.
Pećina-Šlaus N; Hrašćan R
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672638
[TBL] [Abstract][Full Text] [Related]
7. Correction to: A systematic review of immunotherapy in high‑grade glioma: learning from the past to shape future perspectives.
Sferruzza G; Consoli S; Dono F; Evangelista G; Giugno A; Pronello E; Rollo E; Romozzi M; Rossi L; Pensato U
Neurol Sci; 2024 Jun; 45(6):2945. PubMed ID: 38381394
[No Abstract] [Full Text] [Related]
8. Targeting cancer stem cells for treatment of glioblastoma multiforme.
Cho DY; Lin SZ; Yang WK; Lee HC; Hsu DM; Lin HL; Chen CC; Liu CL; Lee WY; Ho LH
Cell Transplant; 2013; 22(4):731-9. PubMed ID: 23594862
[TBL] [Abstract][Full Text] [Related]
9. Induction of antigen-specific cytotoxic T-cell response by dendritic cells generated from ecto-mesenchymal stem cells infected with an adenovirus containing the MAGE-D4a gene.
Hu S; Li B; Shen X; Zhang R; Gao D; Guo Q; Jin Y; Fei Z
Oncol Lett; 2016 Apr; 11(4):2886-2892. PubMed ID: 27073570
[TBL] [Abstract][Full Text] [Related]
10. Cardamonin induces apoptosis by suppressing STAT3 signaling pathway in glioblastoma stem cells.
Wu N; Liu J; Zhao X; Yan Z; Jiang B; Wang L; Cao S; Shi D; Lin X
Tumour Biol; 2015 Dec; 36(12):9667-76. PubMed ID: 26150336
[TBL] [Abstract][Full Text] [Related]
11. Glioma stem cells and immunotherapy for the treatment of malignant gliomas.
Toda M
ISRN Oncol; 2013; 2013():673793. PubMed ID: 23762610
[TBL] [Abstract][Full Text] [Related]
12. [Dendritic cell therapy for malignant glioma].
Yamanaka R; Homma J; Yajima N; Tsuchiya N; Tanaka R
No To Shinkei; 2003 Sep; 55(9):771-80. PubMed ID: 14571839
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell vaccines.
Yamanaka R; Kajiwara K
Adv Exp Med Biol; 2012; 746():187-200. PubMed ID: 22639169
[TBL] [Abstract][Full Text] [Related]
14. Cell- and peptide-based immunotherapeutic approaches for glioma.
Yamanaka R
Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell immunotherapy for malignant gliomas.
Luptrawan A; Liu G; Yu JS
Rev Recent Clin Trials; 2008 Jan; 3(1):10-21. PubMed ID: 18474011
[TBL] [Abstract][Full Text] [Related]
16. Glioma stem cell research for the development of immunotherapy.
Xu Q; Yuan X; Yu JS
Adv Exp Med Biol; 2012; 746():216-25. PubMed ID: 22639171
[TBL] [Abstract][Full Text] [Related]
17. Immunobiology and immunotherapeutic targeting of glioma stem cells.
Madany M; Thomas TM; Edwards L; Yu JS
Adv Exp Med Biol; 2015; 853():139-66. PubMed ID: 25895711
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
